Workday Ventures returned for a $25m funding round for the online healthcare portal, whose shareholders also include GuideWell Mutual and Teladoc.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Hypersonix accelerates with series A
Intel Capital led an $11.5m series A round for Hypersonix, the creator of an artificial intelligence-driven autonomous analytics platform for consumer commerce data.
Dribbble negotiates Creative Market purchase
Creative Market, acquired by Autodesk in 2014 before being spun out three years later, has now been bought by its peer Dribbble for an undisclosed amount.
HealthpointCapital lights the way to IlluminOss acquisition
HealthpointCapital has acquired a majority stake IlluminOss, the orthopaedic implants supplier that raised $28m in a series C round backed by SR One eight years ago.
Pivot Bio picks out $100m
A consortium including Continental Grain, Bunge and Tekfen has pushed the crop nutrition product developer’s total funding to more than $186m.
Nexar looks ahead with $52m
Samsung, Sompo, Nationwide and Micron took part in a series C round that will help the automotive technology developer expand its product offering and geographic footprint.
Figma figures out $50m series D
Andreessen Horowitz has led a $50m series D round for Figma that more than quadrupled the O’Reilly-backed design software developer’s valuation to $2bn.
Salesforce slots into Niche for $35m series C
Salesforce Ventures has thrown its weight behind Niche as the educational matchmaking service prepares to add thousands of schools to its platform.
Robocath puts its heart into series C round
Robocath, which is developing robotic-assisted technology for cardiovascular diseases, has formed a strategic partnership with Microport in connection with a $43.4m round.
Oriente obtains $50m in series B funds
Wix.com was among the investors in a $50m first close of the online lender’s series B round, following $105m in series A funding closed in 2018.
Velo3D adds $28m in series D funding
The metal printing technology producer increased its total funding to $138m in a round led by Petronas-sponsored Piva that included TNSC.
Accent emphasises $63m series B round
GV, AbbVie Ventures and NS Investment have contributed to a series B round for the oncology drug developer, which has now raised a total of $103m.
HLB helps insert more funding into Immunomic
The HLB-led group owns nearly half of vaccine product developer Immunomic Therapeutics following a $61.3m commitment this year.
Slack helps guide $30m to Guru
Guru has closed a $30m series C round backed by returning investor Slack, bringing the sales advice software developer’s total funding to $68m.